Fatal hepatic veno-occlusive disease associated with terbinafine in a liver transplant recipient [1]

Journal of Hepatology

Volumn 38, Issue 3, 2003, Pages 373-374

  Walter, Roland B ^a   Lukaschek, Johannes ^a   Renner, Eberhard L ^a   Müllhaupt, Beat ^a   Bachli, Esther B ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CYCLOSPORIN; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TERBINAFINE;

ADULT; ASCITES; CASE REPORT; CAVOGRAPHY; CLINICAL FEATURE; CONTROLLED STUDY; DEATH; DISEASE COURSE; DRUG FATALITY; GASTROINTESTINAL HEMORRHAGE; HEMODIALYSIS; HUMAN; HUMAN TISSUE; LABORATORY TEST; LETTER; LIVER BIOPSY; LIVER TRANSPLANTATION; LIVER VENOOCCLUSIVE DISEASE; MALE; ONYCHOMYCOSIS; PHYSICAL EXAMINATION; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; TREATMENT WITHDRAWAL; TUBERCULOUS PLEURISY;

EID: 0037335212     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(02)00411-7     Document Type: Letter

References (8)

1. McClellan KJ, Wiseman LR, Markham A. Terbinafine. An update of its use in superficial mycosis. Drugs 1999;58:179-202.
2. Hall M, Monka C, Krupp P, O'Sullivan D. Safety of oral terbinafine: results of a postmarketing surveillance study in 25 884 patients. Arch Dermatol 1997;133:1213-1219.
3. Chambers WM, Millar A, Jain S, Burroughs AK. Terbinafine-induced hepatic dysfunction. Eur J Gastroenterol Hepatol 2001;13:1115-1118.
4. Mintzer SR, Stange J, Klammt S, Peszynski P, Schmidt R, Noldge-Schomburg G. Extracorporeal detoxification using the molecular adsorbent recirculation system for critically ill patients with liver failure. J Am Soc Nephrol 2001;12:75-82.
5. Pegram AA, Kennedy LD. Prevention and treatment of veno-occlusive disease. Ann Pharmacother 2001;35:935-942.
6. Gupta AK, Katz HI, Shear NH. Drug interactions with itraconazole, fluconazole, and terbinafine and their management. J Am Acad Dermatol 1999;41:237-249.
7. Vickers AEM, Sinclair JR, Zollinger M, Heitz F, Glanzel U, Johanson L, et al. Multiple cytochrome P-450s involved in the metabolism of terbinafine suggest a limited potential for drug-drug interactions. Drug Metab Dispos 1999;27:1029-1038.
8. Iverson SL, Uetrecht JP. Identification of a reactive metabolite of terbinafine: insights into terbinafine-induced hepatotoxicity. Chem Res Toxicol 2001;14:175-181.